Related references
Note: Only part of the references are listed.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Optimized PD-L1 scoring of gastric cancer
Birgid Schoemig-Markiefka et al.
GASTRIC CANCER (2021)
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial
Yelena Y. Janjigian et al.
LANCET (2021)
The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis
Dennis Kobelt et al.
ONCOGENE (2021)
Decoding and targeting the molecular basis of MACC1-driven metastatic spread: Lessons from big data mining and clinical-experimental approaches
Jan Budczies et al.
SEMINARS IN CANCER BIOLOGY (2020)
Expression of MACC1 protein in gastric cancer and its effect on proliferation and invasion of gastric cancer cells
Gang Zheng et al.
CELLULAR AND MOLECULAR BIOLOGY (2020)
Multi-institutional validation of the 8th AJCC TNM staging system for gastric cancer: Analysis of survival data from high-volume Eastern centers and the SEER database
Taeil Son et al.
JOURNAL OF SURGICAL ONCOLOGY (2019)
Clinicopathological and prognostic significance of metastasis-associated in colon cancer-1 in gastric cancer: A meta-analysis
Yan Jin et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2019)
Validation of the American Joint Committee on Cancer (AJCC) 8th edition stage system for gastric cancer patients: a population-based analysis
Xingkang He et al.
GASTRIC CANCER (2018)
MACC1 and HGF are associated with survival in patients with gastric cancer
Guokai Dong et al.
ONCOLOGY LETTERS (2018)
Selumetinib plus docetaxel as second-line chemotherapy in KRAS mutant, KRAS amplified or MEK signatured gastric cancer patients: First arm of the umbrella trial in GC though the molecular screening, VIKTORY trial.
Jeeyun Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
MACC1-the first decade of a key metastasis molecule from gene discovery to clinical translation
Harikrishnan Radhakrishnan et al.
CANCER AND METASTASIS REVIEWS (2018)
Correlation between MEK signature and Ras gene alteration in advanced gastric cancer
Soomin Ahn et al.
ONCOTARGET (2017)
SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival
F. Schmid et al.
ONCOGENE (2016)
MACC1 Induces Tumor Progression in Transgenic Mice and Colorectal Cancer Patients via Increased Pluripotency Markers Nanog and Oct4
Clara Lemos et al.
CLINICAL CANCER RESEARCH (2016)
MACC1 upregulation promotes gastric cancer tumor cell metastasis and predicts a poor prognosis
Qiu-ping Xie et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2016)
Increased MACC1 expression indicates a poor prognosis independent of MET expression in gastric adenocarcinoma
Young Wha Koh et al.
PATHOLOGY RESEARCH AND PRACTICE (2016)
HER2 testing in gastric cancer: An update
Lucas Faria Abrahao-Machado et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
The expression of metastasis-associated in colon cancer-1 and KAI1 in gastric adenocarcinoma and their clinical significance
Guoyu Lu et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2016)
Metastatic spread in patients with gastric cancer
Matias Riihimaeki et al.
ONCOTARGET (2016)
Comparison of Gastric Cancer Survival Between Caucasian and Asian Patients Treated in the United States: Results from the Surveillance Epidemiology and End Results (SEER) Database
Jiping Wang et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Metastasis-associated in colon cancer-1 upregulates vascular endothelial growth factor-C/D to promote lymphangiogenesis in human gastric cancer
Li Sun et al.
CANCER LETTERS (2015)
Circulating metastasis associated in colon cancer 1 transcripts in gastric cancer patient plasma as diagnostic and prognostic biomarker
Susen Burock et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas
Suling J. Lin et al.
GUT (2015)
Ethnic Disparities in Gastric Cancer Incidence and Survival in the USA: An Updated Analysis of 1992-2009 SEER Data
Felix H. Lui et al.
DIGESTIVE DISEASES AND SCIENCES (2014)
Expression of MACC1 and c-Met in human gastric cancer and its clinical significance
Tiankang Guo et al.
CANCER CELL INTERNATIONAL (2013)
Metastasis-associated in colon cancer-1 upregulation predicts a poor prognosis of gastric cancer, and promotes tumor cell proliferation and invasion
Lin Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Prognostic Value and Clinical Pathology of MACC-1 and c-MET Expression in Gastric Carcinoma
Jie Ma et al.
PATHOLOGY & ONCOLOGY RESEARCH (2013)
The Role of Pharmacoethnicity in the Development of Cytotoxic and Molecular Targeted Drugs in Oncology
Nagahiro Saijo
YONSEI MEDICAL JOURNAL (2013)
In vivo imaging of colorectal cancer growth and metastasis by targeting MACC1 with shRNA in xenografted mice
Andreas Pichorner et al.
CLINICAL & EXPERIMENTAL METASTASIS (2012)
Over-expression of metastasis-associated in colon cancer-1 (MACC1) associates with better prognosis of gastric cancer patients
Shao-hua Ge et al.
CHINESE JOURNAL OF CANCER RESEARCH (2011)
Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study
Atsushi Ohtsu et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2010)
MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis
Ulrike Stein et al.
NATURE MEDICINE (2009)
Sensitive PCR method for the detection and real-time quantification of human cells in xenotransplantation systems
M Becker et al.
BRITISH JOURNAL OF CANCER (2002)
Share Paper
